Cost & Coverage
How LillyDirect Works, and Where the "Deals" Can Cost You
LillyDirect offers self-pay prices and easy access, but a Senate report raises questions about steering + cost. See how it works and what to watch.
Category
Access & Advocacy
11 stories tagged Access & Advocacy. Browse all of Cost & Coverage
Cost & Coverage
What Medicare's $50 GLP-1 Plan Actually Means for You (Updated Sept 2026)
The $50 Medicare GLP-1 copay applies at every income. See who qualifies, which plans work, and the one fill that ends eligibility.
Cost & Coverage
California AB-1990 and Access to Compounded GLP-1s
California AB-1990 would raise ingredient, record-keeping, and advertising rules for compounded GLP-1 medications. What it could mean for you.
Cost & Coverage
Are Compounded GLP-1s Going Away? Where Things Stand Now (Updated Sept 2026)
A court backed the FDA in August and a warning letter followed in September. See what still allows compounded GLP-1s and what does not.
Cost & Coverage
Why GLP-1 Ads Are Changing: What the FDA's New Marketing Rules Mean for You
FDA warned 30 telehealth companies over GLP-1 marketing claims. Learn what changed, why compounding is not going away, and what to look for.
Cost & Coverage
How Insurance Coverage for GLP-1s Really Works
Learn how GLP-1 insurance coverage works, including prior authorization, appeals, step therapy, and patient responsibilities.
Cost & Coverage
GLP-1 Access in 2026: What Telehealth Platforms Are Doing Differently Than a Year Ago
How telehealth access to GLP-1s is changing in 2026, including intake, follow-up, transparency, and what members should expect.
Cost & Coverage
Medicare, GLP-1s, and TrumpRx: What You Need To Know
Confused about how Medicare may cover GLP-1 weight loss drugs after the TrumpRx deal Learn who may qualify, expected costs, and key dates until 2027.
Cost & Coverage
What to Expect in GLP-1 Therapies for 2026
A clear look at the next wave of GLP-1 drugs in 2026 — launches, filings, access changes and what patients and payers should know.
Medications
Top Mistakes People Make on GLP-1 Therapy
From access issues to mindset and side effects, here are the most common mistakes people make on GLP-1 therapy—and how to fix them.
Medications
Trump’s $150 Ozempic Plan: What’s Real (and What’s Not)
Trump’s plan could cut GLP-1 drug prices — like Ozempic® and Wegovy® — to $150/month. Here’s what’s real, what’s pending, and who it helps.